Monogram Orthopaedics Inc. Common Stock
As of October 7, 2025, Monogram Technologies Inc. was acquired by Zimmer Biomet Holdings, Inc.. Monogram Technologies Inc. engages in developing surgical robot to enable placement of patient optimized orthopedic implants in the United States. It intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and ot… Read more
Monogram Orthopaedics Inc. Common Stock (MGRM) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: -0.267x
Based on the latest financial reports, Monogram Orthopaedics Inc. Common Stock (MGRM) has a cash flow conversion efficiency ratio of -0.267x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-2.30 Million) by net assets ($8.62 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Monogram Orthopaedics Inc. Common Stock - Cash Flow Conversion Efficiency Trend (2017–2024)
This chart illustrates how Monogram Orthopaedics Inc. Common Stock's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Monogram Orthopaedics Inc. Common Stock Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Monogram Orthopaedics Inc. Common Stock ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Hefei Department Store Group Co Ltd
SHE:000417
|
0.042x |
|
SANIONA AB (PUBL)
F:30S
|
N/A |
|
Tianjin Motimo Membrane Tech
SHE:300334
|
-0.028x |
|
Selvas Ai Inc.
KQ:108860
|
-0.006x |
|
Bonava AB (publ)
ST:BONAV-B
|
0.063x |
|
Mayne Pharma Group Limited
PINK:MAYNF
|
0.082x |
|
Seven West Media Limited
PINK:WANHY
|
N/A |
|
Guangdong PAK Corporation Co Ltd
SHE:300625
|
0.041x |
Annual Cash Flow Conversion Efficiency for Monogram Orthopaedics Inc. Common Stock (2017–2024)
The table below shows the annual cash flow conversion efficiency of Monogram Orthopaedics Inc. Common Stock from 2017 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $14.50 Million | $-13.97 Million | -0.963x | +4.72% |
| 2023-12-31 | $13.40 Million | $-13.54 Million | -1.011x | +50.18% |
| 2022-12-31 | $4.15 Million | $-8.42 Million | -2.029x | +22.46% |
| 2021-12-31 | $3.50 Million | $-9.17 Million | -2.617x | -141.63% |
| 2020-12-31 | $4.99 Million | $-5.40 Million | -1.083x | -128.37% |
| 2019-12-31 | $-274.63K | $-1.05 Million | 3.817x | +1630.44% |
| 2018-12-31 | $-1.39 Million | $-306.87K | 0.221x | -75.86% |
| 2017-12-31 | $-677.81K | $-619.37K | 0.914x | -- |